Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Skin symptoms can indicate endocrine disorders and have various treatments.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Surgical repigmentation can permanently restore color to white hair in vitiligo patients.

There's no significant link between blood fat levels and male pattern baldness.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Androgens can help prevent memory problems caused by apoE4.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Silver can help prevent and treat infections but its effectiveness varies and should be weighed against costs and side effects.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Testosterone's muscle-building effects do not require its conversion to DHT.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Overexpressing Dsg3 in mice skin causes excessive cell growth and abnormal skin development.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.